The second shipment of vaccines arrived in Lithuania



[ad_1]

Shipping 9 pm 14 min. It was delivered to the Health Emergencies Center (ESSC) warehouses in the morning and placed in ultra-low temperature freezers purchased specifically for these vaccines, which must be stored at -75 degrees, SAM reports.

The vaccines in this shipment are expected to be used for the second vaccination of medical personnel who have already been vaccinated after the three-week period for the second vaccination has elapsed. This decision may be reviewed once accurate information is received regarding the timing and size of the third shipment delivery.

Vaccinations of medical personnel began on Sunday in five major cities in the country. The first people to get vaccinated in COVID-19 hospitals are those who are at very high risk of developing COVID-19 and who are exposed to the insidious virus on a daily basis. The procedure must be repeated 21 days after the first vaccination to develop immunity to the coronavirus.

It is planned to vaccinate all medical personnel in the country in the first quarter of next year. The subsequent arrival of new vaccine shipments will include vaccinating supportive care and nursing staff and patients, as well as social workers and residents, pharmacists, people over 65, people with comorbid conditions, people with close social contact or prolonged or the public. employees who perform important functions (law enforcement employees, employees working in fire protection and rescue, customs, border guard system, military, employees of educational institutions, energy, food industry, etc.).

When the vaccine reaches all priority groups, we will invite everyone who wants to get vaccinated.
According to experts, 70 percent. vaccinated population would guarantee herd immunity against the coronavirus. Contracts have been signed with six vaccine manufacturers, which are expected to acquire more than 7 million. dose of vaccine.

It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source.



[ad_2]